Home » Topics » BioWorld Science

BioWorld Science
RSS

Searle continues to investigate COX-2 inhibitors for inflammation

Oct. 11, 1996

Novel strategy for AIDS reported by UCSF researchers

Oct. 11, 1996

HIV inhibited by chemokine antagonist

Oct. 11, 1996

IND filed for MiKasome

Oct. 11, 1996

Ingenol derivatives as anti-HIV agents

Oct. 11, 1996

Merck & Co. cleared to market protease inhibitor in EU

Oct. 11, 1996

Anti-HIV agents from Nippon Paper

Oct. 11, 1996

EU approval for Roche AIDS drug

Oct. 11, 1996

Anti-HIV agents from Department of Health & Human Services

Oct. 11, 1996

Genes associated with latent CMV infection discovered

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...